The cost of ruxolitinib can vary significantly based on several factors, including the specific product, dosage, quantity, and the pharmacy or healthcare provider dispensing it. For instance, the brand-name drug Jakafi, which contains ruxolitinib, has a list price that can be substantial.
How much does Jakafi (ruxolitinib) typically cost?
The average retail price for a 30-day supply of Jakafi (ruxolitinib) 5 mg tablets can be over \$10,000. For a higher dosage, such as 15 mg tablets, the cost for the same supply could exceed \$13,000. These figures represent list prices and do not account for potential discounts or insurance coverage.
Are there different versions of ruxolitinib available?
Ruxolitinib is available as a branded medication, Jakafi, manufactured by Incyte Corporation. Generic versions of ruxolitinib have also become available, which may offer a lower cost alternative. The availability and pricing of these generic options can fluctuate.
How does insurance affect ruxolitinib pricing?
Insurance coverage plays a major role in the out-of-pocket cost of ruxolitinib. Patients with comprehensive insurance plans may have significantly lower costs through copays or coinsurance. However, coverage details and copay amounts vary widely between different insurance providers and specific plans. Some patients may also qualify for patient assistance programs offered by the manufacturer to help offset costs.
What is the cost of ruxolitinib for specific conditions?
The cost of ruxolitinib can be influenced by the condition it is prescribed for. Jakafi is approved for treating myelofibrosis, polycythemia vera, and graft-versus-host disease. The duration of treatment and the dosage required for these conditions will impact the overall cost.
Where can I find the most up-to-date pricing information for ruxolitinib?
For the most current and specific pricing information, it is recommended to consult with your healthcare provider or pharmacist. You can also check resources like DrugPatentWatch.com for information on drug pricing and patent exclusivity, which can indirectly influence cost [1]. Websites that provide drug price comparisons may also offer insights, though these often reflect cash prices before insurance.
When might ruxolitinib patent exclusivity end?
Understanding patent exclusivity is important for potential future cost changes due to generic competition. Information regarding the patent status and expiry dates for ruxolitinib can be found on specialized pharmaceutical patent tracking websites [1].
*
**Sources
1. DrugPatentWatch.com.